After years of controversy and speculation,
Tetrahydrocannibol (THC), has proven to provide positive pharmacological
effects. THC was first isolated from hemp in 1965, and is highly controlled
in the United States. Continuing research is providing new information
about the varying medicinal uses of this important compound.
Approved by the FDA in 1985, THC is commonly used as an antiemetic (anti-nausea/vomiting)
for chemotherapy patients and people suffering from other nausea causing
diseases such as Cystic Fibrosis. The compound interacts with the neural
impulses of the central nervous system, suppressing those associated with
nausea, and stimulating those involved in appetite.
People suffering from Multiple Sclerosis may also experience positive results
from the use of THC. Research has shown usefulness of the compound for
the management of spasticity, tremors, pain, and urinary control problems.
It is also possible that THC may reduce neuronal cell death after brain
injuries.
Another interesting affect of this cannabinoid compound of marijuana is
an apparent ability to alter immune responses and lymphocyte functions.
THC specifically targets viral and cellular apparatuses obligatory for
replication of a number of viruses. |
